Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitis.
<h4>Background</h4>Circulating immune cells including autoreactive T cells and monocytes have been documented as key players in maintaining, protecting and repairing the central nervous system (CNS) in health and disease. Here, we hypothesized that neurodegenerative diseases might be ass...
Enregistré dans:
Auteurs principaux: | Ilan Vaknin, Gilad Kunis, Omer Miller, Oleg Butovsky, Shay Bukshpan, David R Beers, Jenny S Henkel, Eti Yoles, Stanley H Appel, Michal Schwartz |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/229b39d1adf24f5281f19de1c1c36e4f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
par: Ghareghani Majid, et autres
Publié: (2021) -
Translational utility of experimental autoimmune encephalomyelitis: recent developments
par: Guerreiro-Cacais AO, et autres
Publié: (2015) -
Testicular steroidogenesis is suppressed during experimental autoimmune encephalomyelitis in rats
par: Ana Milosevic, et autres
Publié: (2021) -
Hsp70 regulates immune response in experimental autoimmune encephalomyelitis.
par: M José Mansilla, et autres
Publié: (2014) -
Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
par: Dhaiban S, et autres
Publié: (2020)